1NY Stock Overview
Designs, manufactures, and sells ultraviolet devices for the treatment of, air, water, and surfaces in France.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
UV Germi SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.86 |
| 52 Week High | €4.24 |
| 52 Week Low | €2.53 |
| Beta | -1.22 |
| 11 Month Change | -9.49% |
| 3 Month Change | 12.16% |
| 1 Year Change | -28.32% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -65.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1NY | DE Machinery | DE Market | |
|---|---|---|---|
| 7D | -2.1% | 4.3% | 4.5% |
| 1Y | -28.3% | 16.8% | 13.4% |
Return vs Industry: 1NY underperformed the German Machinery industry which returned 16.8% over the past year.
Return vs Market: 1NY underperformed the German Market which returned 13.4% over the past year.
Price Volatility
| 1NY volatility | |
|---|---|
| 1NY Average Weekly Movement | 8.7% |
| Machinery Industry Average Movement | 4.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1NY's share price has been volatile over the past 3 months.
Volatility Over Time: 1NY's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 46 | Andres Bordas | www.uvgermi.fr |
UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of, air, water, and surfaces in France. The company offers its products in the areas of drinking water, seawater, dechloramination, wastewater and industrial process water, private pool, legionella, germiserre, industrial clean water, livestock farming industries. It also provides after sales services, such as installations, online repairs, technical advice, diagnosis, spare parts, on-site intervention, and training on the use of the equipment.
UV Germi SA Fundamentals Summary
| 1NY fundamental statistics | |
|---|---|
| Market cap | €9.54m |
| Earnings (TTM) | €290.09k |
| Revenue (TTM) | €8.32m |
32.9x
P/E Ratio1.1x
P/S RatioIs 1NY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1NY income statement (TTM) | |
|---|---|
| Revenue | €8.32m |
| Cost of Revenue | €4.70m |
| Gross Profit | €3.63m |
| Other Expenses | €3.34m |
| Earnings | €290.09k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.091 |
| Gross Margin | 43.58% |
| Net Profit Margin | 3.49% |
| Debt/Equity Ratio | 1.9% |
How did 1NY perform over the long term?
See historical performance and comparison